Business Context and Reporting Period
This Form 8-K Current Report was filed by Black Diamond Therapeutics, Inc. on April 7, 2022, covering events occurring on April 5, 2022. The company is a Delaware corporation listed on the Nasdaq Global Select Market under the symbol BDTX and is classified as an emerging growth company.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate governance changes.
Material Changes
- Resignation of Director: Brad Bolzon, Ph.D., resigned from the Board of Directors effective immediately on April 5, 2022. The company stated this resignation was not due to any disagreement regarding operations, policies, or practices.
- Appointment of Director: Wendy L. Dixon, Ph.D., was appointed to the Board on April 6, 2022, as a Class III director. Her term will last until the 2023 annual meeting of stockholders or until earlier death, resignation, or removal.
- Independence and Compensation: Dr. Dixon is deemed independent under Nasdaq listing standards. She will receive compensation and an initial equity award consistent with the company's Non-Employee Director Compensation Policy. She was not assigned to any committees at the time of appointment.
Guidance, Outlook, and Risks
The filing contains no financial guidance, operational outlook, or discussion of material risks and contingencies. The only unusual item noted is the immediate departure of a board member, which the company explicitly clarified was not the result of a dispute.
Key Facts for Investor Verification
- Verify the independence status and background of the newly appointed director, Wendy L. Dixon, Ph.D.
- Confirm the terms of the equity award granted to Dr. Dixon under the Second Amended and Restated Non-Employee Director Compensation Policy.
- Review the press release (Exhibit 99.1) for any additional context regarding the board composition changes.
- Monitor future filings for the appointment of committee memberships for Dr. Dixon.